Skip to main content

Antimicrobial Resistance

Volume 584: debated on Tuesday 15 July 2014

We are leading cross-Government action to address antimicrobial resistance—AMR—at national and global levels. We published details of how we will measure the success of the UK’s AMR strategy, and we will publish an annual progress report in November. We are considering recommendations in the Science and Technology Committee’s AMR report. I gave evidence to that Committee and we will publish our response in September.

I very much welcome the Government’s international lead on antibiotic resistance, led by the Prime Minister. Does my hon. Friend agree that increasing the unit price of antibiotics and tackling their growing misuse in developing countries is absolutely vital if we are not to face a return to the medical dark ages?

My hon. Friend is quite right to highlight this as a major challenge facing us. I pay tribute to the chief medical officer and to the Prime Minister for the international leadership they have given on this. My hon. Friend will be pleased to hear that the antibiotics market will be considered in its totality by the O’Neill review, which was announced by the Prime Minister on 2 July. It is of course important to bear it in mind that while we look at tackling global antibiotic misuse, we need to balance the need for global conservation measures with accessibility for lower-income countries.